Ryuzo Ueda

30.6k total citations · 2 hit papers
664 papers, 23.2k citations indexed

About

Ryuzo Ueda is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ryuzo Ueda has authored 664 papers receiving a total of 23.2k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Immunology, 167 papers in Molecular Biology and 160 papers in Oncology. Recurrent topics in Ryuzo Ueda's work include T-cell and Retrovirus Studies (85 papers), Lymphoma Diagnosis and Treatment (73 papers) and Hepatitis C virus research (57 papers). Ryuzo Ueda is often cited by papers focused on T-cell and Retrovirus Studies (85 papers), Lymphoma Diagnosis and Treatment (73 papers) and Hepatitis C virus research (57 papers). Ryuzo Ueda collaborates with scholars based in Japan, United States and United Kingdom. Ryuzo Ueda's co-authors include Takashi Ishida, Takashi Takahashi, Shinsuke Iida, Masashi Mizokami, Hirokazu Komatsu, Etsuro Orito, Hiroshi Inagaki, Shigeki Sato, Fuminaka Sugauchi and Shigeru Kusumoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ryuzo Ueda

649 papers receiving 22.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.

1999 620 citations Ryuzo Ueda et al. Blood profile →
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

2012 478 citations Takashi Ishida, Atae Utsunomiya et al. profile →

Peers

Countries citing papers authored by Ryuzo Ueda

Since Specialization

Citations

This map shows the geographic impact of Ryuzo Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuzo Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuzo Ueda more than expected).

Fields of papers citing papers by Ryuzo Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuzo Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuzo Ueda. The network helps show where Ryuzo Ueda may publish in the future.

Co-authorship network of co-authors of Ryuzo Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuzo Ueda. A scholar is included among the top collaborators of Ryuzo Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuzo Ueda. Ryuzo Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment 2022 ·Hematological Oncology ·Yuma Sakamoto, Takashi Ishida, Ayako Masaki, Takayuki Murase, Eiichi Ohtsuka, Morishige Takeshita, (unknown), Hiromi Iwasaki, Asahi Ito, Shigeru Kusumoto, Nobuaki Nakano, Masahito Tokunaga, Kentaro Yonekura, Yukie Tashiro, Shinsuke Iida, Atae Utsunomiya, Ryuzo Ueda, Hiroshi Inagaki	7
2	Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia 2022 ·Leukemia ·(unknown), (unknown), (unknown), Tze King Tan, Ryuzo Ueda, Takashi Ishida, Shinsuke Iida, Takaomi Sanda	6
3	Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab 2021 ·Nature Communications ·Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, (unknown), Susumu Suzuki, Takashi Kojima, Kazuhiro Kakimi, Jun Nakajima, Takeru Funakoshi, Shinsuke Iida, Mikio Oka, Teppei Shimamura, Toshihiko Doi, Yuichiro� Doki, Eiichi Nakayama, Ryuzo Ueda, Hiroyoshi Nishikawa	29
4	Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma 2019 ·Cancer Science ·Keiko Maekawa, Masaki Ri, Miki Nakajima, Akihiro Sekine, Ryuzo Ueda, Masahiro Tohkin, Naoki Miyata, Yoshiro Saito, Shinsuke Iida	18
5	Phase I/ II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma 2017 ·Cancer Science ·Dai Maruyama, Hirokazu Nagai, Yoshinobu Maeda, Takahiko Nakane, Tatsu Shimoyama, Tomonori Nakazato, Rika Sakai, Takayuki Ishikawa, Koji Izutsu, Ryuzo Ueda, Kensei Tobinai	24
6	Clinical significance of tryptophan catabolism in Hodgkin lymphoma 2017 ·Cancer Science ·Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, Asahi Ito, Susumu Suzuki, Tomoko Narita, Shiori Kinoshita, Hisashi Takino, Takashi Yoshida, Masaki Ri, Shigeru Kusumoto, Hirokazu Komatsu, Hiroshi Inagaki, Ryuzo Ueda, Ilseung Choi, Youko Suehiro, Shinsuke Iida	22
7	Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients 2015 ·Clinical Cancer Research ·Koji Kurose, Yoshihiro Ohue, Hisashi Wada, Shinsuke Iida, Takashi Ishida, Takashi Kojima, Toshihiko Doi, Susumu Suzuki, Midori Isobe, Takeru Funakoshi, Kazuhiro Kakimi, Hiroyoshi Nishikawa, Heiichiro Udono, Mikio Oka, Ryuzo Ueda, Eiichi Nakayama	179
8	Prognostic Significance of Tryptophan Catabolism in Adult T-cell Leukemia/Lymphoma 2015 ·Clinical Cancer Research ·Ayako Masaki, Takashi Ishida, Yasuhiro Maeda, Susumu Suzuki, Asahi Ito, Hisashi Takino, (unknown), (unknown), Takashi Yoshida, Shiori Kinoshita, Tomoko Narita, Masaki Ri, Shigeru Kusumoto, Atsushi Inagaki, Hirokazu Komatsu, Akio Niimi, Ryuzo Ueda, Atae Utsunomiya, Hiroshi Inagaki, Shinsuke Iida	42
9	Antitumor Impact of p14ARF on Gefitinib-Resistant Non–Small Cell Lung Cancers 2013 ·Molecular Cancer Therapeutics ·Ken Saito, Nagio Takigawa, Naoko Ohtani, H Iioka, Yuki Tomita, Ryuzo Ueda, Junya Fukuoka, K. Kuwahara, Eiki Ichihara, Katsuyuki Kiura, Eisaku Kondo	12
10	ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Makoto Nakao, Keitaro Matsuo, Hidemi Ito, Kohei Shitara, Satoyo Hosono, Miki Watanabe, Seiji Ito, Akira Sawaki, Shinsuke Iida, Shigeki Sato, Yasushi Yatabe, Kenji Yamao, Ryuzo Ueda, Kazuo Tajima, Nobuyuki Hamajima, Hideo Tanaka	54
11	Potent synergy of dual antitumor peptides for growth suppression of human glioblastoma cell lines 2008 ·Molecular Cancer Therapeutics ·Eisaku Kondo, Takehiro Tanaka, (unknown), Tomotsugu Ichikawa, (unknown), (unknown), Kazuhiro Yoshikawa, Koichi Ichimura, Nobuya Ohara, Akiyoshi Moriwaki, Isao Date, Ryuzo Ueda, Tadashi Yoshino	21
12	Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin 2004 ·Blood ·Jianmin Ding, Hirokazu Komatsu, Atsushi Wakita, (unknown), Masato Ito, Atsushi Satoh, Kazuya Tsuboi, Masakazu Nitta, Hiroshi Miyazaki, Shinsuke Iida, Ryuzo Ueda	234
13	Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus 2001 ·Neuroscience ·Tamaki Iwase, Kosei Ojika, Noriyuki Matsukawa, Hitoe Nishino, Takayuki Yamamoto, Hiroshi Okada, Osamu Fujimori, Ryuzo Ueda	19
14	Lack of Integrated TT Virus (TTV) Genomes Into Cellular DNA in Infected Human Hematopoietic Cells 2000 ·Leukemia & lymphoma ·Yasuhito Tanaka, Masashi Mizokami, Etsuro Orito, Tomoyoshi Ohno, Tatsunori Nakano, Takanobu Kato, Shinsuke Iida, Ryuzo Ueda	10
15	Detection of Zero-Sequence Current and its Current Sensor. 1993 ·IEEJ Transactions on Industry Applications ·(unknown), Ryuzo Ueda, (unknown)	2
16	High response and high accuracy current sensor constituted by using magnetic core. 1991 ·IEEJ Transactions on Industry Applications ·(unknown), Ryuzo Ueda	2
17	A method of improving characteristics of volts/Hertz-controlled induction motors. 1990 ·IEEJ Transactions on Industry Applications ·(unknown), Ryuzo Ueda, (unknown)	1
18	Voltage sensor of high accuracy by using magnetic core. 1990 ·IEEJ Transactions on Industry Applications ·(unknown), Ryuzo Ueda	1
19	Nuclear Localization of Antigens Detected by a Monoclonal Antibody Against a Synthetic Peptide of rfp Finger Protein 1990 ·Hybridoma ·Takashi Kikuchi, Masahide Takahashi, Ryuzo Ueda, (unknown), Tsutomu Seito, Hiroshi Hiai, Izumi Nakashima, Takashi Takahashi	2
20	Stability analysis and stabilizing control of inverter-fed induction motor. 1989 ·IEEJ Transactions on Industry Applications ·(unknown), Ryuzo Ueda, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact